|
|
CFR
|
21 CFR 640.101
Created by admin on Mon Mar 31 21:04:38 GMT 2025 , Edited by admin on Mon Mar 31 21:04:38 GMT 2025
|
|
|
FDA ORPHAN DRUG
|
544616
Created by admin on Mon Mar 31 21:04:38 GMT 2025 , Edited by admin on Mon Mar 31 21:04:38 GMT 2025
|
|
|
FDA ORPHAN DRUG
|
185604
Created by admin on Mon Mar 31 21:04:38 GMT 2025 , Edited by admin on Mon Mar 31 21:04:38 GMT 2025
|
|
|
CFR
|
21 CFR 640.103
Created by admin on Mon Mar 31 21:04:38 GMT 2025 , Edited by admin on Mon Mar 31 21:04:38 GMT 2025
|
|
|
CFR
|
21 CFR 640.102
Created by admin on Mon Mar 31 21:04:38 GMT 2025 , Edited by admin on Mon Mar 31 21:04:38 GMT 2025
|
|
|
CFR
|
21 CFR 640.104
Created by admin on Mon Mar 31 21:04:38 GMT 2025 , Edited by admin on Mon Mar 31 21:04:38 GMT 2025
|
|
|
NDF-RT
|
N0000184165
Created by admin on Mon Mar 31 21:04:38 GMT 2025 , Edited by admin on Mon Mar 31 21:04:38 GMT 2025
|
|
|
FDA ORPHAN DRUG
|
301110
Created by admin on Mon Mar 31 21:04:38 GMT 2025 , Edited by admin on Mon Mar 31 21:04:38 GMT 2025
|
|
|
FDA ORPHAN DRUG
|
943023
Created by admin on Mon Mar 31 21:04:38 GMT 2025 , Edited by admin on Mon Mar 31 21:04:38 GMT 2025
|
|
|
CFR
|
21 CFR 640.100
Created by admin on Mon Mar 31 21:04:38 GMT 2025 , Edited by admin on Mon Mar 31 21:04:38 GMT 2025
|